Drug Trial Radar · NCT00136344
Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery
Last checked: Nov 19, 2026Latest source record: Feb 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35,000
Actual
Start
Sep 2003
Primary completion
Not stated
Study completion May 2006
Sponsor
- Lead sponsor
- City St George's, University of LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- European Society of Cataract and Refractive Surgeons; Santen Gmbh
- First posted
- Aug 29, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cataract is the most important cause of visual impairment and decreased mobility in the elderly. While surgery is usually successful, it is also responsible for permanent loss of vision in up to 0.1% of patients due to severe post-operative infection (endophthalmitis). Because of this risk, surgery is typically performed on one eye at a time leaving the patient with a monocular cataract causing considerable visual impairment with reduction in mobility and quality of life. A second operation is required which often takes place up to one year later. It is not known at present whether the post-operative complication of endophthalmitis can be prevented by perioperative use of antibiotics. This randomised study (masked and placebo-controlled for topical levofloxacin and unmasked for intracameral injection of cefuroxime) sets out to test in 4 groups, each of 8,750 cataract surgery patients, if either topical antibiotic (levofloxacin) perioperatively or an intraocular (intracameral) injection of antibiotic (cefuroxime) at the end of phacoemulsification cataract surgery or the combination provides effective prophylaxis of post-operative infection (endophthalmitis) compared to controls in whom perioperative antibiotics are not used. The result will provide a scientific basis for prophylaxis of infection (endophthalmitis) following cataract surgery in Europe as well as an accurate figure for the incidence of endophthalmitis following phacoemulsification cataract surgery in Europe for the first time.
Conditions
- Endophthalmitis
Interventions
CefuroximeDrug
LevofloxacinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevention of post-operative endophthalmitis following phacoemulsification cataract surgery in Europe due to use of perioperative antibiotics
- Incidence of endophthalmitis in Europe following phacoemulsification cataract surgery
Locations
24 sites in 9 countries. Site status is shown where the registry gives one.
University Eye Clinic, Paracelsus Private Medical University
Salzburg, Austria
University Hospital Antwerp, UZA Ophthalmology
Antwerp, Belgium
University of Gent, Universitaire Zeikenhuis
Ghent, Belgium
Jan Yperman Ziekenhuis
Ieper, Belgium
Centre Hospitalier Universitaire
Liège, Belgium
Oogheelkunde
Melveren, Belgium
Augenklinik Ahaus
Ahaus, Germany
Azienda Ospedaliera di Desenzano del Garda
Desenzano, Italy
Ospedale Borgo Trento
Verona, Italy
Kierownik Katedry i Kliniki
Warsaw, Poland
University Hospital
Coimbra, Portugal
Instituto Oftalmologico VISSUM
Alicante, Spain
La Candelaria University Hospital
La Candelaria, Tenerife, Spain
Hospital Universitario de Canarias
La Laguna, Tenerife, Spain
Hospital Oftalmologico Internacional
Madrid, Spain
Dokuz Eylul University
Izmir, Turkey (Türkiye)
Axminster Hospital
Axminster, United Kingdom
West of England Eye Unit, Royal Devon & Exeter Hospital (Wonford)
Exeter, United Kingdom
Ipswich Hospital
Ipswich, United Kingdom
Moorfields Eye Outreach Unit, Northwick Park Hospital
London, United Kingdom
Moorfields Eye Outreach Unit, St. George's Hospital
London, United Kingdom
St. Thomas' Hospital
London, United Kingdom
Oxford Eye Hospital
Oxford, United Kingdom
Sunderland Eye Infirmary
Sunderland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.